EUVIMEDOpdag EUVIMED
FallberichtLeserbrief

Familial chylomicronemia syndrome: a novel mutation in the lipoprotein lipase gene

S Van Biervliet, S Vande Velde, P De Bruyne, B Callewaert, P Verloo, R De Bruyne

Acta Gastro Enterologica Belgica · 2024

DOI: 10.51821/87.2.12025 ↗

At a glance

Fallbericht in Acta Gastro Enterologica Belgica, 2024. Written by S Van Biervliet and 5 co-authors. Institution: Pediatric gastroenterology, hepatology and nutrition department, Ghent University Hospital, Ghent, Belgium. Major MEDLINE topics: Lipoprotein Lipase, Hyperlipoproteinemia Type I, Mutation. 12 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Familial chylomicronemia syndrome (FCS) (OMIM: 238600) is a rare autosomal recessive disease caused by a biallelic loss-of-function mutation in the lipoprotein lipase (LPL) complex which includes LPL and its co-factors. Patients with FCS have severe hypertiglyceridemia (> 2000 mg/dL). We describe a 15-month-old boy with repeated pancreatitis episodes caused by severe hypertriglyceridemia. Genetic analysis revealed a novel homozygous mutation in the LPL gene, i.e. c.626T>G; p.(Leu209*). The mutation, carried by both parents, has been classified as a type 4 mutation which is likely pathogenic. Treatment aims at decreasing hypertriglyceridaemia by a low-fat diet (< 20g/day) eventually supplemented with medium chain triglyceride (MCT) fat to ensure caloric intake. In 2019, volanesorsen was approved by the European Medicines Agency (EMA) as adjunct treatment for adult patients with genetically proven FCS and persisting episodes of pancreatitis despite the diet.

Subjects

MeSH terms (MEDLINE)

Lipoprotein LipaseHyperlipoproteinemia Type IMutationHumansMaleFemale

Author keywords

childchylomicronemiahyper-triglyceridemialipoprotein lipasepancreatitis

Substances

Lipoprotein Lipase

Authors and institutions

  • Pediatric gastroenterology, hepatology and nutrition department, Ghent University Hospital, Ghent, Belgium.
  • Center for medical genetics, Ghent University Hospital, Ghent, Belgium.
  • Center for metabolic diseases, Ghent University Hospital, Ghent, Belgium.

Cite

APA

Van Biervliet, S., Vande Velde, S., De Bruyne, P., Callewaert, B., Verloo, P., & De Bruyne, R. (2024). Familial chylomicronemia syndrome: a novel mutation in the lipoprotein lipase gene. Acta Gastro Enterologica Belgica. https://doi.org/10.51821/87.2.12025

Vancouver

Van Biervliet S, Vande Velde S, De Bruyne P, Callewaert B, Verloo P, De Bruyne R. Familial chylomicronemia syndrome: a novel mutation in the lipoprotein lipase gene. Acta Gastro Enterologica Belgica. 2024. doi:10.51821/87.2.12025

BibTeX
@article{VanBiervliet2024,
  author = {Van Biervliet, S and Vande Velde, S and De Bruyne, P and Callewaert, B and Verloo, P and De Bruyne, R},
  title = {Familial chylomicronemia syndrome: a novel mutation in the lipoprotein lipase gene},
  journal = {Acta Gastro Enterologica Belgica},
  year = {2024},
  doi = {10.51821/87.2.12025}
}
Start for free →